Literature DB >> 2530003

Ventricular expression of atrial natriuretic polypeptide and its relations with hemodynamics and histology in dilated human hearts. Immunohistochemical study of the endomyocardial biopsy specimens.

G Takemura1, H Fujiwara, K Horike, M Mukoyama, Y Saito, K Nakao, M Matsuda, A Kawamura, M Ishida, M Kida.   

Abstract

To investigate the mechanism of expression of atrial natriuretic polypeptide (ANP) in human ventricles, we conducted an immunohistochemical study of ANP in biventricular endomyocardial biopsy specimens obtained from a total of 49 patients with cardiac dilatation due to dilated cardiomyopathy (21 patients), postmyocarditis (18 patients), or volume overload (five patients) and subjects with no dilatation as controls (five patients). Four-micron thick sections were stained by an indirect immunoperoxidase method using monoclonal antibody to alpha-human ANP as the primary antibody. The frequency of ANP-present myocytes was calculated in each specimen and compared with clinical, echocardiographic, hemodynamic, angiographic, and histologic parameters. ANP-present myocytes were noted in all of the 21 patients with dilated cardiomyopathy, in 11 of the 18 patients with postmyocarditis, in four of the five patients with volume overload, and in zero of the five controls. The mean percentage of ANP-present myocytes was significantly greater in the left-side specimens (35 +/- 37%) than in the right-side ones (2 +/- 4%). The percentage of ANP-present myocytes in the left-side specimens significantly correlated with peak systolic or end-diastolic wall stress (r = 0.67 and 0.58), left ventricular end-systolic or end-diastolic volume index (r = 0.75 and 0.69), or left ventricular end-diastolic pressure (r = 0.42) and inversely correlated with ejection fraction (r = -0.73), systolic left ventricular wall thickness (r = -0.58), or cardiac index (r = -0.30). Expression of ANP was rarely seen in the cases with normal wall stresses, normal ejection fraction, normal volume, or normal myocyte size. However, it was seen frequently even in hearts with normal levels of left ventricular end-diastolic pressure and cardiac index (compensated hearts). The percent of ANP-present myocytes in both sides significantly correlated with size of myocytes (r = 0.48 at right and r = 0.57 at left side) or degree of fibrosis (r = 0.45 at right and r = 0.48 at left side). These results suggest that ANP expression is augmented in the dilated ventricles regardless of the causes of dilatation and that the augmentation is a compensatory mechanism as prevention against decompensation responding to reduced contractility, excess of wall stresses, or both, concomitantly occurring with cardiac dilatation and myocardial hypertrophy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2530003     DOI: 10.1161/01.cir.80.5.1137

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  14 in total

Review 1.  An approach to endomyocardial biopsy interpretation.

Authors:  K S Cunningham; J P Veinot; J Butany
Journal:  J Clin Pathol       Date:  2006-02       Impact factor: 3.411

2.  Contribution of the ventricles and the atrial appendages to the elevation of plasma atrial natriuretic factor (ANF) during pacing-induced heart failure in conscious dogs.

Authors:  W Shen; X Xu; M Ochoa; G A Zeballos; J M Stewart; T H Hintze
Journal:  Basic Res Cardiol       Date:  1996 Jul-Aug       Impact factor: 17.165

3.  Ventricular expression of atrial and brain natriuretic peptides in dilated cardiomyopathy. An immunohistocytochemical study of the endomyocardial biopsy specimens using specific monoclonal antibodies.

Authors:  K Hasegawa; H Fujiwara; K Doyama; M Mukoyama; K Nakao; T Fujiwara; H Imura; C Kawai
Journal:  Am J Pathol       Date:  1993-01       Impact factor: 4.307

Review 4.  Treatment of heart failure in patients with diabetes mellitus.

Authors:  Steven J Lavine; Steven D Gellman
Journal:  Drugs       Date:  2002       Impact factor: 9.546

5.  Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.

Authors:  M Mukoyama; K Nakao; K Hosoda; S Suga; Y Saito; Y Ogawa; G Shirakami; M Jougasaki; K Obata; H Yasue
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

6.  Increased angiotensin-I converting enzyme gene expression in the failing human heart. Quantification by competitive RNA polymerase chain reaction.

Authors:  R Studer; H Reinecke; B Müller; J Holtz; H Just; H Drexler
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

7.  Hypoxia induces release of atrial natriuretic peptide in rat atrial tissue: a role for this peptide during low oxygen stress.

Authors:  M E Ljusegren; R G Andersson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-08       Impact factor: 3.000

8.  ANP expression in the hypertensive heart.

Authors:  Gania Kessler-Icekson; Yael Barhum; Jutta Schaper; Wolfgang Schaper; Ella Kaganovsky; Thomas Brand
Journal:  Exp Clin Cardiol       Date:  2002

9.  The pathogenesis of so-called cardiac rhabdomyoma in swine: a histological, immunohistochemical and ultrastructural study.

Authors:  T Tanimoto; Y Ohtsuki
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

10.  Morphometric analysis of atrial natriuretic peptide-containing granules in atriocytes of rats with experimental congestive heart failure.

Authors:  N Avramovitch; A Hoffman; J Winaver; A Haramati; D Lewinson
Journal:  Cell Tissue Res       Date:  1995-03       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.